Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherEndocrine and Reproductive

Pharmacodynamics of the Type II Calcimimetic Compound, Cinacalcet HCl

Edward F. Nemeth, William H. Heaton, Michael Miller, John Fox, Manuel F. Balandrin, Bradford C. Van Wagenen, Matthew Colloton, William Karbon, Jon Scherrer, Edward Shatzen, Gil Rishton, Sheila Scully, Meiying Qi, Robert Harris, David Lacey and David Martin
Journal of Pharmacology and Experimental Therapeutics October 30, 2003, DOI: https://doi.org/10.1124/jpet.103.057273
Edward F. Nemeth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William H. Heaton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Miller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Fox
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel F. Balandrin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradford C. Van Wagenen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Colloton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Karbon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jon Scherrer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward Shatzen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gil Rishton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sheila Scully
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meiying Qi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Harris
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Lacey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Martin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

Next
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 381 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 381, Issue 2
1 May 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Pharmacodynamics of the Type II Calcimimetic Compound, Cinacalcet HCl
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherEndocrine and Reproductive

Pharmacodynamics of the Type II Calcimimetic Compound, Cinacalcet HCl

Edward F. Nemeth, William H. Heaton, Michael Miller, John Fox, Manuel F. Balandrin, Bradford C. Van Wagenen, Matthew Colloton, William Karbon, Jon Scherrer, Edward Shatzen, Gil Rishton, Sheila Scully, Meiying Qi, Robert Harris, David Lacey and David Martin
Journal of Pharmacology and Experimental Therapeutics October 30, 2003, DOI: https://doi.org/10.1124/jpet.103.057273

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherEndocrine and Reproductive

Pharmacodynamics of the Type II Calcimimetic Compound, Cinacalcet HCl

Edward F. Nemeth, William H. Heaton, Michael Miller, John Fox, Manuel F. Balandrin, Bradford C. Van Wagenen, Matthew Colloton, William Karbon, Jon Scherrer, Edward Shatzen, Gil Rishton, Sheila Scully, Meiying Qi, Robert Harris, David Lacey and David Martin
Journal of Pharmacology and Experimental Therapeutics October 30, 2003, DOI: https://doi.org/10.1124/jpet.103.057273
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Role of Protein Kinase C-Ras-MAPK p44/42 in Ethanol and Transforming Growth Factor-β3-Induced Basic Fibroblast Growth Factor Release from Folliculostellate Cells
  • Therapeutic Actions of an Insulin Receptor Activator and a Novel Peroxisome Proliferator-Activated Receptor γ Agonist in the Spontaneously Hypertensive Obese Rat Model of Metabolic Syndrome X
  • Hepatic Glucocorticoid Receptor Antagonism Is Sufficient to Reduce Elevated Hepatic Glucose Output and Improve Glucose Control in Animal Models of Type 2 Diabetes
Show more ENDOCRINE AND REPRODUCTIVE

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics